Skip to main content

HCAT

Stock
Health Care
Health Information Services

Performance overview

HCAT Price
Price Chart

Forward-looking statistics

Beta
1.60
Risk
66.18%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Company info

SectorHealth Care
IndustryHealth Information Services
Employees1K
Market cap$383.7M

Fundamentals

Enterprise value$322.8M
Revenue$311.3M
Revenue per employee—
Profit margin-23.34%
Debt to equity106.78

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$1.15
Dividend per share—
Revenue per share$4.97
Avg trading volume (30 day)$2M
Avg trading volume (10 day)$3M
Put-call ratio—

Macro factor sensitivity

Growth-0.1
Credit+5.6
Liquidity-1.6
Inflation-0.6
Commodities+1.1
Interest Rates-3.8

Valuation

Dividend yield0.00%
PEG Ratio9.67
Price to sales0.91
P/E Ratio9.67
Enterprise Value to Revenue1.04
Price to book0.75

Upcoming events

Next earnings dayMay 8, 2025
Next dividend day—
Ex. dividend day—

News

Health Catalyst (HCAT) Upgraded to Buy: Here's Why

Health Catalyst (HCAT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research (June 19, 2025)
Time to Play 5 Top-Ranked Stocks With Rising P/E?

Wall Street has been hovering around a record high level, which can trigger overvaluation concerns in some investors' minds. This is because investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings (P/E) ratio.

Benzinga (June 10, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free